TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$10.610-0.170 (-1.577%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$10.780

Kõrge

$10.780

Madal

$10.520

Maht

0.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

530.5M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.28M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $7.44Praegune $10.610Kõrge $11.82

Seotud uudised

PR Newswire

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3...

Vaata rohkem
Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress
PR Newswire

Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first...

Vaata rohkem
Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
PR Newswire

Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of...

Vaata rohkem
Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress
PR Newswire

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2025 financial results and provide a business update after market close on...

Vaata rohkem
Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.